Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Decibel Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +3 vs. Q1 2022
- Shares held
- 17.9M
- +178.0K (+1.0%) vs. Q1 2022
- Total value
- $75.2M
- +$21.4M (+39.9%) vs. Q1 2022
- New holders
- 10
- 9 more added
- Sold out
- 7
- 11 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 48 | $0 | 0.00% | +48 | New |
| Financial Connections Group, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 616 | $2.00K | 0.00% | −78−11.2% | Reduced |
| Simplex Trading, LLC | 1,102 | $4.00K | 0.00% | +1,102 | New |
| Acadian Asset Management LLC | 1,240 | $5.00K | 0.00% | −3,043−71.0% | Reduced |
| UBS Group AG | 1,504 | $6.00K | 0.00% | +1,504 | New |
| Citigroup Inc | 2,169 | $9.00K | 0.00% | +1,638+308.5% | Added |
| Flagship Harbor Advisors, LLC | 10,113 | $43.0K | 0.00% | 00.0% | Unchanged |
| CSS LLC | 10,800 | $45.0K | 0.00% | +10,800 | New |
| Morgan Stanley | 11,029 | $46.0K | 0.00% | −11,812−51.7% | Reduced |
| Bank of America Corp | 10,947 | $46.0K | 0.00% | −7,742−41.4% | Reduced |
| Laurion Capital Management LP | 11,990 | $50.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 14,239 | $60.0K | 0.00% | 00.0% | Unchanged |
| MYDA Advisors LLC | 15,000 | $63.0K | 0.03% | −5,000−25.0% | Reduced |
| Spire Wealth Management | 16,600 | $70.0K | 0.00% | +16,600 | New |
| State Street Corp | 17,160 | $72.0K | 0.00% | +900+5.5% | Added |
| Two Sigma Securities, LLC | 17,683 | $74.0K | 0.01% | +17,683 | New |
| Federated Hermes, Inc. | 20,000 | $84.0K | 0.00% | +5,000+33.3% | Added |
| Atlas Capital Advisors LLC | 25,000 | $105.3K | 0.02% | −16,025−39.1% | Reduced |
| Marquette Asset Management, LLC | 25,704 | $108.0K | 0.03% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 27,310 | $115.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 27,600 | $116.0K | 0.00% | +6,685+32.0% | Added |
| Neuberger Berman Group LLC | 69,000 | $290.0K | 0.00% | +6,175+9.8% | Added |
| Geode Capital Management, LLC | 70,803 | $298.0K | 0.00% | +1,520+2.2% | Added |
| UBS Oconnor LLC | 87,745 | $369.0K | 0.00% | +87,745 | New |
| Bridgeway Capital Management, LLC | 111,982 | $471.0K | 0.01% | −2,946−2.6% | Reduced |
| JPMorgan Chase & Co | 148,224 | $624.0K | 0.00% | −8,145−5.2% | Reduced |
| Bronte Capital Management Pty Ltd. | 163,547 | $689.0K | 0.08% | +323+0.2% | Added |
| ExodusPoint Capital Management, LP | 225,000 | $947.0K | 0.01% | +225,000 | New |
| Barclays PLC | 239,477 | $1.01M | 0.00% | −860−0.4% | Reduced |
| EAM Investors, LLC | 254,981 | $1.07M | 0.26% | +254,981 | New |
| Millennium Management LLC | 264,572 | $1.11M | 0.00% | +225,498+577.1% | Added |
| Newtyn Management, LLC | 310,000 | $1.30M | 0.25% | +310,000 | New |
| Harvard Management Co Inc | 328,798 | $1.38M | 0.16% | 00.0% | Unchanged |
| Bessemer Group Inc | 494,071 | $2.08M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 622,937 | $2.62M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 801,629 | $3.38M | 0.90% | −24,793−3.0% | Reduced |
| Alphabet Inc. | 1,636,258 | $6.89M | 0.37% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,792,308 | $7.55M | 0.01% | +18,617+1.0% | Added |
| BlackRock Inc. | 1,894,481 | $7.98M | 0.00% | −2,742−0.1% | Reduced |
| TRV GP III, LLC | 3,139,685 | $13.2M | 5.41% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $20.8M | 0.40% | 00.0% | Unchanged |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −330,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −275,001−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −263,600−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,308−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −19,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,846−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |